3[3]Elmslie JL,Silverstone JT,Mann JI,et al.Prevalence of overweight and obesity in bipolar patients.J Clin Psychiatry,2000,61(1):179～184.
4[4]Blackbum GL.Weight and antipsychotic medication.J Clin Psychiatry,2000,61(Suppl,8):36～41.
5[5]Keshavan MS,Kennedy JS.Drug-induced dysfunction in psychiatry.New York.Hemisphere publishing corporation,1992.273～285.
6[6]Matthews KL,Chen CP,Esiri MM,et al.Noradrenergic changes,aggressive behavior and cognition in patients with dementia.Biol Psychiatry,2002,51(5):407～416.
7[7]Helzer JE,Guze SB.Psychoses,Affective disorders,and dementia.New York:Basic book inc,1986.69～88.
8[8]Lenox RH,Hahn CG.Overview of the mechanism of action of lithium in the brain:fifty-year update.J Clin Psychiatry,2000,61(Suppl,9):5～15.
3Fung HT, Lai CH, Wong OF, et al. Two cases of methemoglobinemia fol- lowing zopiclone ingestion[J]. Clin Toxicol(Phila) ,2008,46(2) :167 - 170.
4Bogzazzi F, Bartalena L, Campomori A, et al. Treatment with lithium pre- vents Serum thyroid hormone increase after thionamide withdrawal and ra- dioiodine therapy in patients with Graves' disease[J]. Clin Endocrinol Metab ,2002,87 (10) : 4 490 - 4 495.
5Fausto B, Luigi B, Sandra B, et al. Comparison of Radioiodine With Ra- dioiodine Plus Lithium in the Treatment of Graves' Hyperthyroidism [J]. Clin Endocrinol Metab, 1999,84 (2) : 499 - 503.
6Markowitz GS, Radhakrishnan J, Kambham N, et al. Lithium nephrotoxicity: a progressive combined glomcrular and tubulointerstitial nephropathy[J]. See Nephrol,2000,11(8): 1 439 - 1 448.
7Elmslie JL, Silverstone IT, Mann JI, et al. Prevalence of overweight and obesity in bipolar patients [ J ]. Clin Psychiatry, 2000,61 ( 1 ) : 179 - 184.
8Presne C, Fakhouri F, Noel H, et al. Lithium - induced nephropathy: rate of progression and prognostic factors[J]. Kidney Int,2003,64(2): 585 - 592.
9Marcussen N. Atubular glomeruli and the structural basis for chronic renal failure[J]. Lab Invest, 1992,66(3): 265 - 284.
